A PhRMA Blog » Alzheimer's
5 FOLLOWERS
We are creating a place where we can share ideas, provide the perspective of America's biopharmaceutical companies and, most importantly, listen to you. Read about the latest pharmaceutical research related to Alzheimer's disease. We strive to conduct effective advocacy for public policies that encourage the discovery of important, new medicines for patients by biopharmaceutical..
A PhRMA Blog » Alzheimer's
1y ago
This week marks a somber anniversary for patients with Alzheimer’s. Last year, the Centers for Medicare & Medicaid Services (CMS) finalized a national coverage determination (NCD) that, for the first ..read more
A PhRMA Blog » Alzheimer's
1y ago
Before medicines can be made available to patients, they often begin as ideas that are based on newly discovered molecules and cells, strange phenomena or little-understood processes in the body. The ..read more
A PhRMA Blog » Alzheimer's
1y ago
With neurodegenerative diseases affecting millions of individuals in the United States, now is an important time to spotlight the increasing impact these diseases have on our country’s aging ..read more
A PhRMA Blog » Alzheimer's
1y ago
In comments submitted this week, PhRMA urged the Centers for Medicare & Medicaid Services (CMS) to withdraw its proposed national coverage determination (NCD) for monoclonal antibodies (mAbs) for the ..read more
A PhRMA Blog » Alzheimer's
1y ago
This year’s Alzheimer’s and Brain Awareness Month offers an important opportunity to remember the severe toll that Alzheimer’s takes on patients and family caregivers. Unfortunately, this year also ..read more